Sleep Disorders Clinical Trials Review H1, 2020 - ResearchAndMarkets.com

DUBLIN--()--The "Sleep Disorders Global Clinical Trials Review, H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering.

This clinical trial report, Sleep Disorders Global Clinical Trials Review H1, 2020 provides an overview of Sleep Disorders Clinical trials scenario.

This report provides top line data relating to the clinical trials on Sleep Disorders. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. The report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

Report Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Key Topics Covered

  1. Report Guidance
  2. Clinical Trials Report Coverage
  3. Clinical Trials by Region
  4. Clinical Trials and Average Enrollment by Country
  5. Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  6. Top Five Countries Contributing to Clinical Trials in Europe
  7. Top Countries Contributing to Clinical Trials in North America
  8. Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  9. Top Five Countries Contributing to Clinical Trials in Central and South America
  10. Clinical Trials by G7 Countries: Proportion of Sleep Disorders to Central Nervous System Clinical Trials
  11. Clinical Trials by Phase in G7 Countries
  12. Clinical Trials in G7 Countries by Trial Status
  13. Clinical Trials by E7 Countries: Proportion of Sleep Disorders to Central Nervous System Clinical Trials
  14. Clinical Trials by Phase in E7 Countries
  15. Clinical Trials in E7 Countries by Trial Status
  16. Clinical Trials by Phase
  17. In Progress Trials by Phase
  18. Clinical Trials by Trial Status
  19. Clinical Trials by End Point Status
  20. Subjects Recruited Over a Period of Time
  21. Clinical Trials by Sponsor Type
  22. Prominent Sponsors
  23. Top Companies Participating in Sleep Disorders Therapeutics Clinical Trials
  24. Prominent Drugs
  25. Latest Clinical Trials News on Sleep Disorders
  26. Nov 20, 2019: Harmony Biosciences announces publication of data in sleep from two clinical studies of WAKIX (pitolisant)
  27. Clinical Trial Profile Snapshots

Companies Mentioned

  • Takeda Pharmaceutical Co. Ltd.
  • Merck & Co. Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Johnson & Johnson
  • Vanda Pharmaceuticals Inc.
  • Jazz Pharmaceuticals PLC
  • Pfizer Inc.
  • Sumitomo Dainippon Pharma Co. Ltd.
  • Sanofi
  • Bioprojet SCR

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/v1l2jg

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900